Cancer drug gives hope
A BREAKTHROUGH drug being trialled in Australia has seen more than a third of terminally ill patients with rare blood cancer go into full remission.
Of the 15 St Vincent’s Hospital multiple myeloma patients granted access to the wonder-drug Daratumumab, five have already entered full remission – and many of the others more recently added to the trial are expected to soon join them as they progress.
“The response I have had in my patients has been astounding,” St Vincent’s haematologist Hang Quach said from Melbourne.
“By the second cycle (eight weeks), virtually every one of my patients has gone to partial response; and by the third or fourth cycle, a lot of them are already in complete response.”